Life Sciences Consulting Services Market – Demand for RWE, PV, HEOR

The life science industry is quickly developing and is witnessing growing complexity, stringent regulations, the need for faster innovation, and the trend towards digitalization. This in turn drives the demand for pharma and biotech consulting services including drug development, regulatory affairs, scientific writing, economic affairs, quality assurance and compliance, real-world evidence (RWE), and pharmacovigilance (PV).

The global Life Sciences Consulting Services market is valued at over $10 billion in 2021 and is expected to grow at a CAGR of ~10%, driven by increasing R&D in advanced therapies, stringent regulatory compliance, rising need for digitalization/technical expertise, and growing demand for RWE, PV, HEOR, market access services.

Surging Demand for Advanced Therapies Consulting

Advanced therapies, such as cell and gene therapies and personalized vaccines require specialized expertise throughout the development, manufacturing, and regulatory process. To effectively develop a product and obtain a centralized market authorization (MA) in Europe and/or a biologic license authorization (BLA) in the US, it is essential to have up-to-date knowledge and skills of the constantly evolving Advanced Therapy Medicinal Products (ATMP) landscape. With rapidly expanding research on cell and gene therapies, there is robust demand for ATMP consulting as it requires experts with specific experience in regulatory strategy, CMC, medical communications, and clinical development.

Product Commercialization/Market Access – Key Element for the Success of a New Drug

Previously, a drug's ability to enter the market was nearly entirely based on its efficacy and safety. However, pharmaceutical companies are now progressively required to demonstrate how a new drug improves patient outcomes, reduces the burden of the healthcare system as a whole, and is worth its price. To support these criteria, pharmaceutical companies are looking at a more holistic view of patient treatment, providing better RWE and therefore a stronger value proposition for decision-makers. Additionally, complex regulatory and reimbursement pathways, varied evidence requirements, and long procedural timelines pose risk to successful access and launch. All these features are boosting the demand for market access services including Health Economics and Outcomes Research (HEOR), PV, and RWE strategy and consulting across the globe.

Demand for Technology/IT Consulting Services Picking Up Fast

Pharma and biotech industry is increasingly looking for technology/IT consulting services to digitize their operations, migrate to the cloud, make use of advanced technologies like AI/ML, and modernize existing IT infrastructures.

Explore Premium Report on Life Sciences Consulting Services Market @ https://meditechinsights.com/life-sciences-consulting-services-market/

North America Leads the Adoption of Life Sciences Consulting Services Market

North America has a major market share of global life sciences consulting services market revenues. This is primarily attributed to the rising biopharmaceutical industry, significant R&D spending in the US, the presence of several big pharma companies like J&J and Pfizer in this region, quick acceptance of digital and IT, strict FDA regulations, and a greater focus on advanced therapies.

Companies Adopting Inorganic Growth Strategies to Increase their Market Share

Companies in the life sciences consulting services market are concentrating on adding to or growing their portfolio with services including RWE, HEOR, PV, medical communications, and analytics as a significant growth strategy. This is evident in some of the recent M&As in these areas.

For instance,

In Jan 2022, TriNetX, the global network of healthcare organizations driving real-world research acquired Advera Health Analytics, the leader in pharmacovigilance software, analytics, and data
In July 2020, imc group, a London headquartered medical communications agency acquired Porterhouse Medical Group

To influence growth opportunities in the life sciences consulting services market, private equities are also making investments in this space. Ex. Lumanity (Arsenal Capital Partners, 2022), Clearview Healthcare Partners (GHO Capital, 2021), and ProPharma (Odyssey Investment Partners, 2020).

Competitive Landscape Analysis of Life Sciences Consulting Services Market

The global life sciences consulting services market is highly competitive and fragmented. Some of the key/promising players in this market include IQVIA, Parexel, Certara, Huntsworth, PharmaLex, Halloran Consulting, Ashfield, Fishawack, Envision Pharma, Science Group, Indegene, Fingerpaint, Eversana, Lumanity, ClearView, ProPharma, ProductLife Group, Deallus, RTI, Evidera (PPD), Target RWE, OPEN Health, Genesis Research, and QbD Group.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/